http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35658047

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 777
issn 0919-8172
1442-2042
issueIdentifier 9
pageRange 772-777
publicationName International journal of urology : official journal of the Japanese Urological Association
startingPage 772
bibliographicCitation Harada KI, Sato R, Bando Y, Sano A, Matsushita Y, Tamura K, Terakawa T, Furukawa J, Fujimoto N, Fujisawa M, Miyake H. Efficacy and safety of pembrolizumab and axitinib as first-line treatment for patients with advanced renal cell carcinoma: Real-world experience in Japan. Int J Urol. 2023 Sep;30(9):772–7. doi: 10.1111/iju.15230. PMID: 37345413.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_87a03b162b11b996a593a3af8264ee41
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_750e27ff50a198843644793502b2e583
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8159-9793
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7736-1216
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1340-4739
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_853689ca0bb259396311db43d5b22f89
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0242-9674
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_32496b971de0521eb0d54a9bb6b1dd0e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4447-6516
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5256-6415
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_26c14b1ff5c5f8844bf2becc28ae13b2
date 2023-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1111/iju.15230
https://pubmed.ncbi.nlm.nih.gov/37345413
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8739
https://portal.issn.org/resource/ISSN/1442-2042
https://portal.issn.org/resource/ISSN/0919-8172
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Efficacy and safety of pembrolizumab and axitinib as first‐line treatment for patients with advanced renal cell carcinoma: Real‐world experience in Japan
discusses http://id.nlm.nih.gov/mesh/M0586473
http://id.nlm.nih.gov/mesh/M0489638
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D007680Q000473
http://id.nlm.nih.gov/mesh/D007680Q000188
http://id.nlm.nih.gov/mesh/D002292Q000473
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000077784Q000009
http://id.nlm.nih.gov/mesh/D012189
http://id.nlm.nih.gov/mesh/D007564
http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID108157
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7170
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6450551

Total number of triples: 44.